Charmacy Pharmaceutical Co., Ltd.

HKEX:2289.HK

8.35 (HKD) • At close September 16, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

20232022202120202019201820172016201520142013
Revenue 4,403.6334,175.2793,793.6183,991.7113,492.7833,935.2464,095.8353,669.7813,397.1333,014.0592,401.231
Cost of Revenue 4,110.893,906.673,559.5013,754.3083,272.1353,700.1243,888.4163,489.9353,232.4312,877.6182,297.253
Gross Profit 292.744268.61234.117237.403220.648235.122207.419179.847164.702136.441103.978
Gross Profit Ratio 0.0660.0640.0620.0590.0630.060.0510.0490.0480.0450.043
Reseach & Development Expenses 00000000000
General & Administrative Expenses 47.53349.64748.40245.746.50454.15949.50338.75540.3837.16233.972
Selling & Marketing Expenses 37.56112.92103.44985.97577.473.98368.07851.77840.29635.75725.137
SG&A 37.56165.049151.559143.043128.15130.186119.55692.64880.67672.91959.109
Other Expenses -0.066-0.372-0.128-0.0370.0660.2190.2390000
Operating Expenses 178.012116.084163.418154.943138.803143.552125.55490.237103.67872.40758.102
Operating Income 66.19593.48774.42488.07685.19799.08183.71883.45984.02663.52244.869
Operating Income Ratio 0.0150.0220.020.0220.0240.0250.020.0230.0250.0210.019
Total Other Income Expenses Net -41.17928.567-41.443-33.334-30.152-35.425-23.861-7.377-42.451-17.587-15.555
Income Before Tax 67.42122.05432.98154.74255.04563.65559.85776.08141.57545.93529.314
Income Before Tax Ratio 0.0150.0290.0090.0140.0160.0160.0150.0210.0120.0150.012
Income Tax Expense 16.07531.6739.82814.18614.89118.89315.56219.62315.2169.497.095
Net Income 51.34590.47223.15340.55640.15345.43344.7659.34826.35936.44522.219
Net Income Ratio 0.0120.0220.0060.010.0110.0120.0110.0160.0080.0120.009
EPS 0.480.840.210.380.370.420.410.520.320.460
EPS Diluted 0.480.840.210.380.370.420.410.520.320.460
EBITDA 141.819119.188103.518109.87106.302117.52297.83994.93793.00873.24754.836
EBITDA Ratio 0.0320.0290.0270.0280.030.030.0240.0260.0270.0240.023